Clinical Trial Update: Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating KBP-042 for efficacy and safety in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• KBP-042

Snippet

Sponsor: KeyBioscience AG | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED